Wellington Management Group’s Roivant Sciences ROIV Stock Holding History

Wellington Management Group’s Portfolio ROIV Stock Details ROIV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$95.1M	Buy	2,687,870 +1,724,588	+179%	+$51M	0.02%	563
2026 Q1	$26.7M	Buy	+963,282	New	+$24.7M	0.01%	912
2024 Q2	–	Sell	-70,618	Closed	-$744K	–	1957
2024 Q1	$744K	Sell	70,618 -13,569,798	-99%	-$146M	﹤0.01%	1748
2023 Q4	$153M	Sell	13,640,416 -1,202,560	-8%	-$11.7M	0.03%	451
2023 Q3	$173M	Sell	14,842,976 -353,579	-2%	-$4M	0.03%	403
2023 Q2	$153M	Buy	15,196,555 +3,167,758	+26%	+$28.3M	0.03%	446
2023 Q1	$88.8M	Buy	+12,028,797	New	+$99M	0.02%	570

Other funds holding ROIV

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Wellington Management Group's ROIV Position: Q2 2026 in Review

Wellington Management Group increased its Roivant Sciences (ROIV) stake by 179% in Q2 2026, buying an estimated $51M and bringing the position to 2,687,870 shares worth $95.1M. The position accounts for 0.02% of the portfolio, ranked #563.

Wellington Management Group first reported a position in ROIV in Q1 2023 and has held it in 7 quarters since. The position peaked at $173M in Q3 2023. 498 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

Wellington Management Group held 2,687,870 shares of Roivant Sciences worth $95.1M as of Q2 2026.
Wellington Management Group bought 1,724,588 Roivant Sciences shares in Q2 2026, an estimated $51M.
Roivant Sciences made up 0.02% of Wellington Management Group's portfolio in Q2 2026, its #563 holding.
Wellington Management Group first reported a position in Roivant Sciences in Q1 2023 and has held it in 7 quarters since.
Wellington Management Group's Roivant Sciences position peaked at $173M in Q3 2023.
498 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.